Exchange: NASDAQ·Updated 03:59 PM EDT
News
all
press releases
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout?
In April, the stock faced resistance near $30 and saw selling pressure in the following weeks.  
Stocktwits
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides
This decision would reverse a 2023 ban that resulted in the removal of 14 peptides from a list of products that the FDA allowed compounding pharmacies to produce.
Stocktwits
Why Did DOCS Stock Plunge 35% In Pre-Market Today?
Multiple brokerages cut their price target on the stock after Doximity reported a fall in third-quarter earnings and a soft fourth-quarter revenue outlook.
Stocktwits
Teladoc’s New Amazon Tie-Up Sparks Retail Sentiment Surge Even As Stock Swings Wildly
Following the ouster of CEO Jason Gorevic last year, the telehealth company has been trying to chart a recovery path.
Stocktwits

Advertisement|Remove ads.